Cigna Stock Falls 11% After Missing Quarterly Profit Estimates on Higher Medical Costs

Reuters
01-30

(Reuters) - Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.

Shares of the company fell 11% before the bell.

The plan, called "stop-loss insurance", entails the insurer covering for employers' self-funded plans when their costs surpass a certain threshold due to catastrophic or unexpected medical claims.

The company forecast annual profit per share of at least $29.50, below analysts estimates of $31.50 per share, according to data compiled by LSEG.

Cigna manages employer-sponsored healthcare plans, and unlike its peers, has a smaller presence in the Medicare Advantage market, where insurers have been grappling with increased medical costs driven by demand for healthcare services among older adults.

The health insurer is in the process of selling its Medicare Advantage business to Health Care Service Corp. The divestiture, announced last year, is expected to close in the first quarter of 2025.

For the quarter, its medical care ratio - the percentage of premiums spent on medical care - came in at 87.9%, up from 82.2% a year ago. Analysts expected a ratio of 84.84% for the reported quarter.

"While higher medical costs in our stop-loss product impacted fourth-quarter earnings, we are taking corrective actions to address these near-term pressures," said CEO David Cordani.

On an adjusted basis, Cigna posted fourth-quarter profit of $6.64 per share, compared with estimates of $7.82.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10